Biosimilars in UK gain NICE recommendation

Posted 05/02/2016

Biosimilars may be set to increase their market share in the UK after the country’s healthcare cost watchdog recommended that rheumatoid arthritis patients i...

more
Biosimilar etanercept offered at 47% discount i... Biosimilars/General | Posted 05/02/2016
Generics applications under review by EMA – Dec... Generics/General | Posted 05/02/2016
Positive phase III results for cetuximab and in... Biosimilars/Research | Posted 05/02/2016
Celgene settles Revlimid patent litigation with... Biosimilars/News | Posted 05/02/2016
Lack of health insurance limits access to biolo... Biosimilars/Research | Posted 05/02/2016
Australian approval for infertility biosimilar... Biosimilars/News | Posted 05/02/2016
12th EGA LEGAL AFFAIRS CONFERENCE Conferences | Posted 05/02/2016
EBG BIOSIMILARS CONFERENCE 2016 Conferences | Posted 05/02/2016
Prescribing similar biotherapeutic products in... Biosimilars/Research | Posted 29/01/2016
Biosimilars applications under review by EMA –... Biosimilars/General | Posted 29/01/2016
Further capping of generics in Japan Policies & Legislation | Posted 29/01/2016
Pharmacists’ attitudes towards domestic generic... Generics/Research | Posted 29/01/2016
FDA finalizes guidance for biosimilars meetings Guidelines | Posted 29/01/2016
Partnerships driving similar biologics developm... Biosimilars/Research | Posted 29/01/2016
FDA approval for generic antibiotic and arrhyth... Generics/News | Posted 29/01/2016
Filgrastim follow-on biological approved in Brazil Biosimilars/News | Posted 29/01/2016
What happened in biosimilars during 2015 Biosimilars/General | Posted 22/01/2016
Paediatric use of low-cost generic programs in... Generics/Research | Posted 22/01/2016
Roche and India's Glenmark reach truce over gen... Generics/News | Posted 22/01/2016
Generics market share in Europe Reports | Posted 22/01/2016
Domestic biologicals cost less in India Biosimilars/Research | Posted 22/01/2016
Eisai acquires Chinese generics maker Pharma News | Posted 22/01/2016
Bevacizumab non-originator biological approved... Biosimilars/News | Posted 22/01/2016
6th Annual OTC Pharma Asia 2016 Conferences | Posted 22/01/2016
Pharmaceutical Congress China 2016 Conferences | Posted 22/01/2016
Biopharma Development & Production 2016 Conferences | Posted 22/01/2016
Top 10 most read GaBI Online articles in 2015 Pharma News | Posted 15/01/2016
Barriers to biologicals competition Biosimilars/Research | Posted 15/01/2016
Physicians’ and pharmacists’ perspectives on ge... Generics/Research | Posted 15/01/2016
EMA accepts application for etanercept biosimilar Biosimilars/News | Posted 15/01/2016
Michigan introduces new biosimilars substitutio... Policies & Legislation | Posted 15/01/2016
Doctors in the US should remember to prescribe... Biosimilars/Research | Posted 15/01/2016
Low costs and less stringent regulatory require... Biosimilars/Research | Posted 15/01/2016
Use of generics in cardiovascular diseases Generics/Research | Posted 08/01/2016
FDA approves first follow-on insulin glargine t... Biosimilars/News | Posted 08/01/2016
Inflectra PBS listing expected to deliver savin... Biosimilars/General | Posted 08/01/2016
Pegfilgrastim biosimilar as safe and effective... Biosimilars/Research | Posted 08/01/2016
Factors affecting the uptake of ‘similar biolog... Biosimilars/Research | Posted 08/01/2016
Generics reduce costs and increase access Reports | Posted 08/01/2016
Korean approval for infliximab biosimilar Biosimilars/News | Posted 11/12/2015
Pharmaceutical pricing and reimbursement policies Generics/Research | Posted 11/12/2015
Biosimilar adalimumab application submitted to EMA Biosimilars/News | Posted 11/12/2015
Regulation and uptake of ‘similar biologics’ in... Biosimilars/Research | Posted 11/12/2015
Teva and Takeda partner for generics in Japan Pharma News | Posted 11/12/2015
more